OBJECTIVE: To determine the accuracy of placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and inhibin A in singleton and multiple-gestation pregnancies for predicting preeclampsia (PE) and small for gestational age (SGA). STUDY DESIGN: A prospective cohort nested in a randomized controlled trial of antioxidant supplementation for the prevention of PE. Plasma biomarkers were evaluated at 12 to 18 (visit 1) and 24 to 26 (visit 2) weeks' gestation and expressed as adjusted multiples of the median. RESULTS: Multiple-gestation pregnancy (74/772) had a significant impact on all biomarkers' levels. PlGF was the best predictor of PE and SGA. At a 10% false-positive rate, PlGF at visit 1 had 21% sensitivity for predicting PE in singleton versus 60% in multiple-gestation pregnancies. PlGF at visit 1 had a 31% sensitivity in singleton and 27% in multiple-gestation pregnancies for SGA prediction. CONCLUSION: PlGF level was a good predictor of subsequent PE as early as 12 to 18 weeks in multiple-gestation pregnancies but was not clinically useful enough to be used as a single marker. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
RCT Entities:
OBJECTIVE: To determine the accuracy of placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1), and inhibin A in singleton and multiple-gestation pregnancies for predicting preeclampsia (PE) and small for gestational age (SGA). STUDY DESIGN: A prospective cohort nested in a randomized controlled trial of antioxidant supplementation for the prevention of PE. Plasma biomarkers were evaluated at 12 to 18 (visit 1) and 24 to 26 (visit 2) weeks' gestation and expressed as adjusted multiples of the median. RESULTS: Multiple-gestation pregnancy (74/772) had a significant impact on all biomarkers' levels. PlGF was the best predictor of PE and SGA. At a 10% false-positive rate, PlGF at visit 1 had 21% sensitivity for predicting PE in singleton versus 60% in multiple-gestation pregnancies. PlGF at visit 1 had a 31% sensitivity in singleton and 27% in multiple-gestation pregnancies for SGA prediction. CONCLUSION:PlGF level was a good predictor of subsequent PE as early as 12 to 18 weeks in multiple-gestation pregnancies but was not clinically useful enough to be used as a single marker. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Authors: Gaea S Moore; Amanda A Allshouse; Virginia D Winn; Henry L Galan; Kent D Heyborne Journal: Pregnancy Hypertens Date: 2015-06-23 Impact factor: 2.899
Authors: Manouk L E Hendrix; Judith A P Bons; Roy R G Snellings; Otto Bekers; Sander M J van Kuijk; Marc E A Spaanderman; Salwan Al-Nasiry Journal: Fetal Diagn Ther Date: 2019-05-08 Impact factor: 2.587
Authors: Mohammad S Ghaemi; Adi L Tarca; Roberto Romero; Natalie Stanley; Ramin Fallahzadeh; Athena Tanada; Anthony Culos; Kazuo Ando; Xiaoyuan Han; Yair J Blumenfeld; Maurice L Druzin; Yasser Y El-Sayed; Ronald S Gibbs; Virginia D Winn; Kevin Contrepois; Xuefeng B Ling; Ronald J Wong; Gary M Shaw; David K Stevenson; Brice Gaudilliere; Nima Aghaeepour; Martin S Angst Journal: J Matern Fetal Neonatal Med Date: 2021-03-02
Authors: Pensée Wu; Caroline van den Berg; Zarko Alfirevic; Shaughn O'Brien; Maria Röthlisberger; Philip Newton Baker; Louise C Kenny; Karolina Kublickiene; Johannes J Duvekot Journal: Int J Mol Sci Date: 2015-09-23 Impact factor: 5.923
Authors: Szymon Kozłowski; Anna Stelmaszczyk-Emmel; Iwona Szymusik; Aleksandra Saletra-Bielińska; Robert Brawura-Biskupski-Samaha; Paweł Pietruski; Agnieszka Osińska; Katarzyna Kosińska-Kaczyńska Journal: Diagnostics (Basel) Date: 2021-06-29